• About
  • Subscribe
  • Advertise
  • Contact
Thursday, January 22, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

CERA and WHO develop vision screening app

by Staff Writer
October 31, 2023
in Eye research institutions, News, Ophthalmic organisations, Products
Reading Time: 3 mins read
A A
Vision screening app by CERA and WHO

WHOEyes is intended to be complementary to regular vision tests.

Share on FacebookShare on Twitter

The Centre for Eye Research Australia (CERA) and the World Health Organization (WHO) have developed an app to increase access to vision tests.

Launched on World Sight Day by WHO director-general Dr Tedros Adhanom Ghebreyesus, WHOEyes is an app that allows anybody with a smartphone to test their vision and learn about protecting their eyes.

According to the organisations, the app is designed to reduce preventable vision loss worldwide and is intended to be complementary to regular vision tests to help people identify potential problems early so they can seek professional care.

“Globally, more than one billion people have a vision impairment that could be easily addressed with surgery or a simple pair of glasses,” said Tedros.

“Regular check-ups can ensure that eye disease is detected early, and vision loss is prevented.”

WHOEyes can be used by anyone but it’s expected to be particularly useful in countries with limited access to eyecare services.

Dr Lisa Zhuoting Zhu, principal investigator of ophthalmic epidemiology at CERA, said WHOEyes will provide teachers in remote schools with an easy way of spotting vision issues that would affect a child’s education.

“If vision loss is observed among the children, they can be referred to an eye specialist to check whether they have refractive errors such as lazy eye or severe cases of short or far sightedness,” she said.

Zhu said the app will also be helpful for older people and those living in remote and rural areas without access to eye specialists.

“If people can test their visual acuity at home, it will mean they won’t have to travel unnecessarily,” she said.

Refractive errors aren’t the only cause of vision loss, and Zhu said WHOEyes could also be an effective triage tool for eye disease.

“Often by the time people visit an eye specialist, they may already have the later stages of eye disease,” she said.

“By testing vision annually or every six months, you can notice smaller changes in vision and detect any issues earlier.”

How it works

According to a statement by the organisations, WHOEyes is available to all smartphone users to test their visual acuity, allows for testing of short and long-distance vision and is available in six languages.

The app automatically detects the distance between the smartphone and user to ensure tests are accurate. Depending on the user’s results, the app may recommend seeking an eyecare professional for further testing.

Zhu suggested people using the app track their results.

“Next time you take the test, you can compare your results with your previous one,” she said. “It’s best to track your results annually or every six months.”

According to a statement, WHOEyes is suitable for anyone aged over eight years and can be downloaded for Android via Google Play and iPhone via the App Store.

More reading

Cylite takes ground-breaking tech a step further

Australia marks World Sight Day 2023

FDA clears first online vision test in the US

Related Posts

The investigational device combines ultra-widefield OCT with AI to enable rapid, non-invasive imaging of the retinas of premature infants. Image: Nenov Brothers/stock.adobe.com.

Handheld ultra-widefield OCT and AI system advances ROP diagnosis

by Staff Writer
January 22, 2026

Researchers at the OHSU Casey Eye Institute have developed the world’s first handheld ultra-widefield optical coherence tomography (OCT) system for...

A common Parkinson’s disease medication may reduce the risk of AMD progression. Image: Siam/stock.adobe.com

Parkinson’s drug may lower risk of AMD progression, study finds

by Staff Writer
January 22, 2026

A recent study suggests that levodopa, a common Parkinson’s disease medication, may reduce the risk of progression from early-stage age-related...

The implant combines lab-grown human embryonic stem cell-derived RPE cells with an ultrathin synthetic parylene scaffold. Image: catalin/stock.adobe.com

Stem-cell retinal implant shows promise in dry AMD

by Staff Writer
January 21, 2026

Researchers in the United States are advancing a groundbreaking stem-cell retinal implant for people with advanced dry age-related macular degeneration...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited